Zekri Jamal, Dreosti Lydia M, Ghosn Marwan, Hamada Emad, Jaloudi Mohamed, Khorshid Ola, Larbaoui Blaha
College of Medicine, King Faisal Specialist Hospital and Research Centre, Alfaisal University, Jeddah, Saudi Arabia.
Department of Medical Oncology, University of Pretoria, Pretoria, South Africa.
J Multidiscip Healthc. 2015 Jul 27;8:335-44. doi: 10.2147/JMDH.S85538. eCollection 2015.
The management of renal cell carcinoma (RCC) has evolved considerably in recent years. This report represents the consensus of 22 relevant medical specialists from Africa and the Middle East region engaged in the management of RCC. Partial or radical nephrectomy is the standard of care for most patients with localized RCC. It is essential that patients are followed up appropriately after surgery to enable local and distant relapses to be identified and treated promptly. The treatment of advanced/metastatic disease has changed dramatically with the introduction of targeted therapies. Follow-up of these patients enables therapy optimization and assessment of response to treatment. There was universal agreement on the importance of management of RCC by a multidisciplinary team supported by a multidisciplinary tumor board. Barriers hindering this approach were identified. These included lack of awareness of the benefits of multidisciplinary team role, poor communication among relevant disciplines, time constraints, and specifics of private practice. Other challenges include shortage of expert specialists as urologists and oncologists and lack of local management guidelines in some countries. Solutions were proposed and discussed. Medical educational initiatives and awareness activities were highlighted as keys to encouraging cooperation between specialties to improve patients' outcome. Establishing combined genitourinary cancer clinics and formal referral systems should encourage a culture of effective communication. Joining forces with professionals in peripheral areas and the private sector is likely to help standardize care. Sustained action will be required to ensure that all patients with RCC in the region benefit from up-to-date care.
近年来,肾细胞癌(RCC)的管理有了很大进展。本报告代表了来自非洲和中东地区从事RCC管理的22位相关医学专家的共识。部分或根治性肾切除术是大多数局限性RCC患者的标准治疗方法。术后对患者进行适当随访至关重要,以便能够及时识别和治疗局部及远处复发。随着靶向治疗的引入,晚期/转移性疾病的治疗发生了巨大变化。对这些患者进行随访有助于优化治疗并评估治疗反应。对于由多学科肿瘤委员会支持的多学科团队管理RCC的重要性,大家达成了普遍共识。确定了阻碍这种方法的障碍。这些障碍包括对多学科团队作用的益处缺乏认识、相关学科之间沟通不畅、时间限制以及私人执业的特殊性。其他挑战包括泌尿外科医生和肿瘤内科医生等专家短缺,以及一些国家缺乏当地管理指南。提出并讨论了解决方案。医学教育举措和提高认识活动被强调为鼓励各专业之间合作以改善患者治疗结果的关键。建立联合泌尿生殖系统癌症诊所和正式转诊系统应有助于形成有效沟通的文化。与周边地区和私营部门的专业人员合作可能有助于规范医疗服务。需要持续采取行动,以确保该地区所有RCC患者都能受益于最新的治疗。